Table 2 Oncological characteristics comparing ISLT (n = 8) and PVEres (n = 12) group
PVEres | ISLT | p-value | |
|---|---|---|---|
n = 12 | n = 8 | ||
Oncological characteristics | |||
Tumor Type n (%) | 0.7 | ||
CRLM | 3 (25) | 2 (25) | |
RCCLM | 0 | 1 (12.5) | |
HCC | 3 (25) | 2 (25) | |
CCC | 5 (41.7) | 3 (37.5) | |
NET | 1 (8.3) | 0 | |
TNM stage n (%) | |||
T-stage | 0.88 | ||
1 | 2 (16.7) | 2 (28.6) | |
2 | 2 (16.7) | 1 (14.3) | |
3 | 7 (58.3) | 3 (42.9) | |
4 | 1 (8.3) | 1 (14.3) | |
N-stage n (%) | 0.31 | ||
0 | 7 (58.3) | 2 (25) | |
1 | 4 (33.3) | 3 (37.5) | |
2 | 0 | 1 (12.5) | |
Nx | 1 (8.3) | 2 (25) | |
M-stage n (%) | 0.21 | ||
0 | 7 (58.3) | 2 (25) | |
1 | 5 (41.7) | 5 (62.5) | |
Mx | 0 | 1 (12.5) | |
Grading n (%) | 0.2 | ||
G2 | 8 (66.7) | 8 (100) | |
G3 | 3 (25) | 0 | |
Gx | 1 (8.3) | 0 | |
Neoadjuvant chemotherapy n (%) | 1 | ||
Yes | 3 (25) | 2 (25) | |
No | 9 (75) | 6 (75) | |
R-status n (%) | 0.34 | ||
R0 | 11 (91.7) | 7 (87.5) | |
R1 | 1 (8.3) | 0 | |
Rx | 0 | 1 (12.5) | |
Number of lesions (mean + SD) | 2 + 1.9 | 4 + 4.6 | 0.36 |
Maximum tumor diameter (mean + SD) | 80.5 + 47.1 | 66.3 + 27.7 | 0.51 |